Skip to main content

Advertisement

Log in

Cerebral amyloid angiopathy with focal presentation—about 3 cases

  • Short Report
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Cerebral amyloid angiopathy (CAA) is a common cerebrovascular disease involved in ischemic and hemorrhagic strokes, and its progression is correlated to cognitive decline. In vivo diagnosis of CAA is guided by the modified Boston criteria, with the presence of multiple intracerebral hemorrhage or cerebral microbleeds (CMB), or single hemorrhage and cortical superficial siderosis. The diagnosis of CAA is highly dependent on the quality of imaging and the advent of susceptibility-weighted imaging (SWI) sequences has improved sensitivity of MRI to detect hemosiderin deposition and CMB, hallmarks of CAA. We report here 3 clinical cases of patients with Alzheimer’s disease and a focal form (i.e., not disseminated) of probable CAA, diagnosed with SWI sequences. Focal CAA may require closer attention and could offer keys in the understanding of both Alzheimer’s disease and CAA pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Anonymized data will be available from the corresponding author upon reasonable request.

References

  1. Yamada M (2015) Cerebral amyloid angiopathy: emerging concepts. J Stroke 17:17–30. https://doi.org/10.5853/jos.2015.17.1.17

    Article  PubMed  PubMed Central  Google Scholar 

  2. Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM (2017) Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 140:1829–1850. https://doi.org/10.1093/brain/awx047

    Article  PubMed  PubMed Central  Google Scholar 

  3. Greenberg SM, Charidimou A (2018) Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria. Stroke 49:491–497. https://doi.org/10.1161/STROKEAHA.117.016990

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shams S, Martola J, Cavallin L, Granberg T, Shams M, Aspelin P, Wahlund LO, Kristoffersen-Wiberg M (2015) SWI or T2*: which MRI sequence to use in the detection of cerebral microbleeds? The Karolinska Imaging Dementia Study. Am J Neuroradiol 36:1089–1095. https://doi.org/10.3174/ajnr.A4248

    Article  CAS  PubMed  Google Scholar 

  5. Jack CR, Bennett DA, Blennow K et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14:535–562. https://doi.org/10.1016/j.jalz.2018.02.018

    Article  PubMed  PubMed Central  Google Scholar 

  6. Pasquier F, Leys D, Weerts JG et al (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268–272. https://doi.org/10.1159/000117270

    Article  CAS  PubMed  Google Scholar 

  7. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972. https://doi.org/10.1136/jnnp.55.10.967

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fotiadis P, van Rooden S, van der Grond J, Schultz A, Martinez-Ramirez S, Auriel E, Reijmer Y, van Opstal AM, Ayres A, Schwab KM, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Hedden T, Rosand J, Viswanathan A, Wermer M, Terwindt GM, Sperling RA, Polimeni JR, Johnson KA, van Buchem MA, Greenberg SM, Gurol ME (2016) Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. Lancet Neurol 15:811–819. https://doi.org/10.1016/S1474-4422(16)30030-8

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ronsin S, Deiana G, Geraldo AF, Durand-Dubief F, Thomas-Maisonneuve L, Formaglio M, Desestret V, Meyronet D, Nighoghossian N, Berthezène Y, Honnorat J, Ducray F (2016) Pseudotumoral presentation of cerebral amyloid angiopathy–related inflammation. Neurology 86:912–919. https://doi.org/10.1212/WNL.0000000000002444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT (2017) Focal cerebral β-amyloid angiopathy: a distinct clinicopathologic presentation. Neurol Clin Pract 7:444–448. https://doi.org/10.1212/CPJ.0000000000000354

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antoine Garnier-Crussard.

Ethics declarations

Conflict of interest

We declare that we have no conflict of interest.

Ethical approval

N/A

Informed consent

Patients and/or family gave their consent for the publication of this short report.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garnier-Crussard, A., Taki, A., Bonnefoy, M. et al. Cerebral amyloid angiopathy with focal presentation—about 3 cases. Neuroradiology 62, 1195–1197 (2020). https://doi.org/10.1007/s00234-020-02450-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-020-02450-8

Keywords

Navigation